Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03355456 · ClinicalTrials.gov registry record · NA
Low Voltage-Directed Catheter Ablation for Atrial Fibrillation
A NA study of Atrial Fibrillation - Symptomatic, sponsored by Ohad Ziv.
- Recruiting
- Registry status
- NA
- Development phase
- 250
- Enrollment target
- 1
- Study location
NCT03355456: Recruiting NA study of Atrial Fibrillation - Symptomatic, sponsored by Ohad Ziv.
NCT03355456 is a NA study of Atrial Fibrillation - Symptomatic that is actively recruiting participants, run by Ohad Ziv. The registered enrollment target is 250 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (82% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03355456, a NA study of Atrial Fibrillation - Symptomatic, is actively recruiting participants, sponsored by Ohad Ziv.
- RECRUITING
- Registry status
- NA
- Development phase
- 250 participants
- Enrollment target
- 1
- Study location
Study Summary
A two-pronged approach to evaluate long term success of non-paroxysmal ablation when using a: 1. specified low voltage-directed with pulmonary vein isolation (LD+PVI) approach compared to , 2. an approach of pulmonary vein isolation (PVI) alone.
Primary Outcome
The primary endpoint is freedom from sustained symptomatic or asymptomatic atrial arrhythmia (atrial fibrillation, atrial flutter or atrial tachycardia - AT/AF) i.e.; NO change from sinus rhythm to atrial arrhythmia between 3 -12 months after ablation. Recurrence of AF/AT excludes the 3 month blanking period. Sustained AF/AT is defined as \>30 seconds as recorded on a monitoring device.
Conditions Studied
Interventions
- PROCEDURE Radiofrequency ablation
Study Locations (1)
Ohio
- MetroHealth Medical Center - Cleveland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 250 participants |
| Start Date | 2019-07-14 |
| Est. Completion | 2027-12-31 |
| Phase | NA |
What NCT03355456 shows while recruiting
NCT03355456 is an interventional study that assigns participants to a tested intervention. The registered 250 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (82% lower).
The record links to 1 condition, with Atrial Fibrillation - Symptomatic appearing as the primary indexed condition, and to 1 intervention - of which Radiofrequency ablation is the first listed.
NCT03355456 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT03355456 about?
NCT03355456 is a clinical study titled "Low Voltage-Directed Catheter Ablation for Atrial Fibrillation". A two-pronged approach to evaluate long term success of non-paroxysmal ablation when using a: 1. specified low voltage-directed with pulmonary vein isolation (LD+PVI) approach compared to , 2. an approach of pulmonary vein isolation (PVI) alone.
What is the current status of trial NCT03355456?
This trial is currently recruiting. It is a NA study. The enrollment target is 250 participants. The study started on 2019-07-14. Estimated completion is 2027-12-31.
What conditions does trial NCT03355456 study?
This clinical trial studies the following conditions: Atrial Fibrillation - Symptomatic.
What interventions are being tested in trial NCT03355456?
The interventions under investigation include: Radiofrequency ablation (PROCEDURE).
Who is sponsoring clinical trial NCT03355456?
This trial is sponsored by Ohad Ziv, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03355456 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03355456's enrollment target sits among peer trials
250 410th of 2000 higher than 1,567 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00483249 · 250 participants · NA
Endovascular Exclusion of Thoracoabdominal and/or Paravisceral Abdominal Aortic Aneurysm
- NCT00777712 · 250 participants
Mechanisms Underlying Impaired Diabetic Wound Healing
- NCT01451502 · 250 participants · NA
Infusion of Cell Populations From Unlicensed Umbilical Cord Blood Units
- NCT01771718 · 250 participants
Pilot Study on In-vivo Non-invasive Skin Imaging Using Multiphoton Microscopy
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI